Digital transformation in life sciences has been saved
Perspectives
Digital transformation in life sciences
How pharma and medtech can shift from doing digital to being digital
Digital transformation is no longer a buzzword—it’s a strategic imperative. Life Science companies should tackle enterprise-wide digital transformation head-on with a holistic, business-driven approach.
Read our executive interviews featured in the Wall Street Journal CIO Journal
Digital transformation: A new competitive imperative
A convergence of events—COVID-19, the burgeoning of digital health, economic uncertainty, ecosystem collaboration, and new competition—has affected life sciences by both accelerating and advancing digital initiatives already underway, and it has jump-started future initiatives.
In an increasingly digital, patient-centered, and insight-driven health care world, a fragmented approach to digital transformation no longer suffices. To remain competitive and realize a sustainable industry advantage, companies should move from merely doing digital to being digital, embedding enterprise-wide strategies into their core operations. Starting now, executive leadership should take a targeted transformation approach, integrating innovation into commercial, product, and operations functions to enhance collaboration, productivity, and market agility.
Why? Because connected and enterprise digital transformations are not a technology fad; rather they are a competitive imperative to help amplify science, insights, productivity, and collaboration to succeed in a digital health ecosystem.
True enterprise digital transformations go above function, brand, and market, and they are focused at the value chain, business unit, therapeutic area, strategic focus (e.g., patient, therapy leadership), enterprise, or ecosystem level. Enterprise digital transformation programs also challenge traditional business models and abandon point digital capabilities for end-to-end, connected digitization across interactions, experiences, insights, and processes.
In a common use case, companies leverage digital transformations to evolve from a transactional model to an insight-driven, value-based organization, where connected digital strategies redefine how they deliver patient care, optimize operations, and enhance market responsiveness. To achieve this state, life sciences companies should leverage enterprise digital transformation to connect and elevate existing digital efforts into a wider enterprise digital strategy and transformation to drive broader business value.
Digital strategy objectives:
• Customer-in-focus models: Drive business strategies and operations from the patient and HCP
• Always-on agility: Rapid, nonlatent responses to planned or unforeseen environmental conditions
• Fully connected community: Enterprise insights from democratized data and a fully connected business
• Intelligent optimization: Management by exception and continually optimized processes enabled by more extensive data (e.g., IoT), intelligent workflow, and human-machine decision-making
• Predictive, holistic, insight-driven analytics: Accelerated and improved insights and decision-making across the enterprise
• Flexible, virtual, unbounded workforce and workplace: Leverage talent wherever it is
No strategic business transformation is easy. While core enterprise transformation mantras hold for digital transformations (e.g., strategy-led, dynamic executive leadership and business-impact focus), there are five key questions life sciences executives should address to successfully define and structure their digital transformation.
1. What is my holistic digital ambition? The strategic business question is what digital transformation strategy fits a company's strategic objectives, financial and competitive needs.
2. How do I value and position a broader digital transformation? Successful companies use a structured digital value model that consists of value, operational performance, and capability plays (and measures).
3. How do I activate my ecosystem to accelerate digital value and realization? Life sciences companies should activate their wider ecosystem to leverage non-traditional approaches to mitigate the four Cs of enterprise transformation challenges: Cash, capacity, competency and control (i.e., risk).
4. How do I structure, mobilize, and align my organization for success? Digital transformations should be structured to meet challenges and mobilize for success – i.e., with the goal of delivering on critical strategic objectives.
5. How do we future-proof our capabilities and become an adaptable organization? Leaders should view digital transformation as an ongoing, enterprise evolution to innovate, engage, and execute more agilely, effectively, and efficiently to build and sustain competitiveness.
The combination of people, experiences, processes, data, and insights, driven by digital technology and delivered in a connected manner for higher business value, is what we call a digital pillar. Digital pillars and their related pivots are a means to propel and focus an organization along its digital journey. The focus of a digital transformation should be defined by choices within, and across, five driving digital transformation pillars.

Moving forward in a digital world
To rethink their future, life sciences organizations must move beyond siloed digital adoption and instead embrace comprehensive, enterprise-wide digital transformation initiatives. These actions, when aligned with transformative strategies for core business areas, can position companies to build a competitive advantage in the evolving digital health landscape.
Companies that fail to successfully navigate enterprise digital transformations risk becoming minimized in the future digital health care ecosystem. Enterprise digital transformations deliver more significant industry advantages by integrating innovation and digital technologies into existing and emerging business models. This approach not only transforms core commercial, product, and operational strategies but also accelerates the ability to deliver improved health outcomes, foster patient trust, and achieve broader business impact while inspiring employees and stakeholders.
Related content
Recommendations
2024 life sciences tech trends
Unveiling the next wave of medtech and biopharma innovation
AI readiness in medtech
Unlocking new dimensions of efficiency and innovation